Perous

Chicago – The injection of new generation obesity of NOVO Nordisk targeting amyline hormone has shown substantial weight loss in an early study, but similar efficiency between different doses and high levels of side effects raise questions about the Novo dose in the future. In phase 1/2, the study testing the medication, called Amycretine, patients […]